
What the analyst said
UBS analyst Timothy Arcuri lowered the price target on Marvell (NASDAQ: MRVL) to $300 (from $340) while maintaining a Buy rating.
Cite this note: Price Target, "UBS Lowers Marvell Price Target to $300," August 17, 2026. https://price-target.com/2026/08/17/173293/
Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Goldman Sachs on Marvell
Goldman Sachs price targets on Marvell
6 calls from March 6, 2026 to August 27, 2026. The target went from $100 to $195 (+95%). The rating stayed Hold.
$100$200$300$100$125This note$300
March 2026Today
Goldman Sachs target
- August 27, 2026Downgraded to Hold, target cut from $300 (−35%)Hold$195
- August 17, 2026 This noteUpgraded to Buy, target raised from $195 (+54%)Buy$300
- August 12, 2026Target raised from $180 (+8%)Hold$195
- May 28, 2026Target raised from $125 (+44%)Hold$180
- May 27, 2026Target raised from $100 (+25%)Hold$125
- March 6, 2026Earliest call shownHold$100




